🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/08/2015 5,84 6,10 5,70 5,75 -1,37% 6,93% 1.288.200
17/08/2015 5,50 5,84 5,40 5,83 +6,00% 8,00% 1.232.500
14/08/2015 5,73 5,73 5,42 5,50 -4,68% 5,43% 1.615.700
13/08/2015 5,79 6,00 5,67 5,77 -1,37% 5,70% 1.108.300
12/08/2015 5,95 5,97 4,83 5,85 -1,85% 19,16% 2.026.900
11/08/2015 6,10 6,18 5,92 5,96 -2,45% 4,20% 915.900
10/08/2015 6,12 6,37 5,98 6,11 +0,00% 6,37% 1.129.700
07/08/2015 6,18 6,19 5,90 6,11 -1,61% 4,69% 1.339.200
06/08/2015 6,85 6,95 6,17 6,21 -8,27% 11,39% 1.536.200
05/08/2015 6,11 7,17 6,11 6,77 +12,27% 17,35% 2.982.000
04/08/2015 6,04 6,15 5,89 6,03 -0,17% 4,30% 916.700
03/08/2015 6,19 6,21 5,97 6,04 -2,27% 3,80% 888.800
31/07/2015 6,10 6,22 6,02 6,18 +1,31% 3,28% 592.200
30/07/2015 6,19 6,19 6,01 6,10 -1,37% 2,91% 875.300
29/07/2015 6,23 6,30 6,01 6,19 -1,51% 4,65% 994.100
28/07/2015 6,33 6,41 6,11 6,28 -0,48% 4,74% 920.900
27/07/2015 6,40 6,40 6,04 6,31 -2,17% 5,70% 1.048.700
24/07/2015 6,66 6,80 6,42 6,45 -3,73% 5,71% 712.700
23/07/2015 6,56 6,88 6,55 6,70 +1,82% 5,03% 740.200
22/07/2015 6,60 6,61 6,41 6,58 -0,45% 3,03% 501.900
21/07/2015 6,66 6,72 6,55 6,61 -0,75% 2,55% 486.400
20/07/2015 6,87 6,90 6,65 6,66 -2,77% 3,64% 538.500
17/07/2015 6,90 6,94 6,77 6,85 -0,58% 2,46% 447.100
16/07/2015 6,91 7,00 6,84 6,89 +0,29% 2,32% 514.100
15/07/2015 7,00 7,10 6,83 6,87 -1,43% 3,86% 681.600
14/07/2015 6,79 6,99 6,77 6,97 +2,95% 3,24% 626.600
13/07/2015 6,74 6,80 6,60 6,77 +1,35% 2,97% 637.600
10/07/2015 6,78 6,92 6,50 6,68 +1,06% 6,19% 1.354.800
09/07/2015 6,66 6,76 6,54 6,61 +0,61% 3,30% 765.500
08/07/2015 6,64 6,90 6,53 6,57 -2,95% 5,65% 1.017.900